Vitro Diagnostics, Inc.: Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter
st, 2021, financial results of operations.
Vitro Biopharma recorded quarter ended January 31
st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic.
Revenues in the first quarter of 2021 of $127,492 were down 21% over the $161,888 recorded in the prior fourth quarter. The decrease in the current first quarter revenue was on account of the Research products weak seasonal quarter due to the universities and institutions generally are not as active during the holiday periods.
During the quarter the Stem Cell clinics offshore continued to be shut down and the cosmetic clinics were only partially operating at reduced capacity.
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Vitro Diagnostics, Inc : Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.